Clinical Drug Experience Knowledgebase

Aggression (Phase 1)

Blast Crisis (Phase 1)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 2)

Coronavirus Infections (Phase 2)

Diabetic Foot (Phase 2)

Endometrial Neoplasms (Phase 3)

Foot Ulcer (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Infections (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Prolymphocytic (Phase 1)

Liposarcoma (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Mantle-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Melanoma (Phase 1)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Glandular and Epithelial (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Nerve Sheath Neoplasms (Phase 1)

Neurofibrosarcoma (Phase 1)

Polycythemia (Phase 2)

Polycythemia Vera (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Rectal Neoplasms (Phase 1)

Recurrence (Phase 1)

Sarcoma (Phase 1)

Sarcoma, Alveolar Soft Part (Phase 1)

Sarcoma, Ewing (Phase 1)

Severe Acute Respiratory Syndrome (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Syndrome (Phase 2)

Thrombocythemia, Essential (Phase 2)

Thrombocytosis (Phase 2)

Thymoma (Phase 2)

Thymus Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Ulcer (Phase 2)